GLPBio

Immunology/Inflammation

Read More about this category

The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.

Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].

BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].

Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.

Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].

 

References

[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.

[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.

[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.

[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.

[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.

[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.

[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.

[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.

Research Areas

Products Related to Immunology/Inflammation(4435)

  • GC81687 structure
    GC81687cis-V-11-0711
    CAS: 1428338-79-7
    Purity: >98%

    cis-V-11-0711 is the cis form of V-11-0711.

  • GC81690 structure
    GC81690BI1071
    Purity: >98.50%

    BI1071 is an orally active Nur77-Bcl-2 apoptotic pathway modulator.

  • GC81695 structure
    GC81695DIM-3,5-Cl2
    CAS: 2595179-74-9
    Purity: >99.00%

    DIM-3,5-Cl2 is an inverse NR4A1/NR4A2 agonist with K D values of 7.7 μM and 12.0 μM for NR4A1 and NR4A2, respectively.

  • GC81725 structure
    GC81725TRPV1 antagonist 10
    CAS: 896584-55-7
    Purity: >98.50%

    TRPV1 antagonist 10 is an orally active and potent TRPV1 antagonist ( IC 50 = 33.06 nM), moderate to weak URAT1 ( IC 50 = 22.51 μM) and GLUT9 (60.25% at 50 μM) inhibitor.

  • GC81730 structure
    GC81730Misitatug blivedotin
    Purity: >98%

    Misitatug blivedotin (RC88) is an antibody-drug conjugate ( ADC ) targeting mesothelin ( MSLN ).

  • GC81731 structure
    GC81731Hericene A
    CAS: 157207-54-0
    Purity: >98.50%

    Hericene A is an orally active aromatic hericene derivative.

  • GC81752 structure
    GC817528-Deoxylactucin
    CAS: 65725-10-2
    Purity: >95.00%

    8-Deoxylactucin is an orally active sesquiterpene lactone.

  • GC81754 structure
    GC81754(E)-FOBISIN101
    CAS: 1370281-06-3
    Purity: >95.50%

    (E)-FOBISIN101 is a 14-3-3 protein-protein interaction ( 14-3-3 protein-protein interaction ) inhibitor, with IC 50 values of 9.3 and 16.4 μM for disrupting the binding of 14-3-3ζ or 14-3-3γ to PRAS40, respectively.

  • GC81757 structure
    GC817573-Ethoxy-5,6-dibromosalicylaldehyde
    CAS: 20041-64-9
    Purity: >99.50%

    3-Ethoxy-5,6-dibromosalicylaldehyde is an IRE1/ERN1 inhibitor, with an IC 50 of 0.12 μM, a K i of 71-88 nM, and a K d of 100 nM against the ribonuclease activity of hIRE1α, as well as an IC 50 of 4.8 μM against yeast Ire1.

  • GC81758 structure
    GC81758HDAC11-IN-5
    Purity: >98.00%

    HDAC11-IN-5 is a selective, potent and orally active HDAC11 inhibitor with an IC 50 of 0.021 μM.

  • GC81760 structure
    GC81760Shepherdine
    CAS: 3000-36-0
    Purity: >98.00%

    Shepherdine, a harmala-type indole and tetrahydro-β-carboline alkaloid, is an antioxidant.

  • GC81761 structure
    GC817614-Methoxycinnamic acid ethyl ester
    CAS: 1929-30-2
    Purity: >98.50%

    4-Methoxycinnamic acid ethyl ester (Ethyl p-methoxycinnamate) is an orally active natural compound found.

  • GC81762 structure
    GC81762Mitoflaxone
    CAS: 87626-55-9
    Purity: >99.50%
  • GC81763 structure
    GC81763Coelenterazine TFA
    Purity: >99.00%

    Coelenterazine TFA is a luminescent enzyme substrate for apoaequorin and Renilla luciferase.

  • GC81767 structure
    GC81767BAY-1128688
    CAS: 1428988-21-9
    Purity: >98.00%

    BAY-1128688 is a potent, orally active and selective AKR1C3 inhibitor with IC 50 < 2 nM.

  • GC81771 structure
    GC81771RANKL-IN-1 formate
    Purity: >99.50%

    RANKL-IN-1 formate is a selective receptor activator of nuclear factor-κB ligand inhibitor ligand ( RANKL ) inhibitor with a K D value of 7.6 μM.

  • GC81772 structure
    GC81772Epibestatin hydrochloride
    CAS: 100992-60-7
    Purity: >98.00%

    Epibestatin hydrochloride is an epimer of Bestatin, a DPP4 inhibitor and protease inhibitor, with an IC 50 of 17 μM against DPP4.

  • GC81818 structure
    GC8181811β,13-Dihydrolactucopicrin
    CAS: 125519-47-3
    Purity: >98%

    11β,13-Dihydrolactucopicrin is a sesquiterpene lactone and the main bitter component of chicory root.

  • GC81825 structure
    GC81825ASO-4625
    Purity: >98.00%

    ASO-4625 is a 20-nucleotide gapmer antisense oligonucleotide with a full phosphorothioate backbone and 2'-O-(2-methoxy) ethyl ribose modifications, which targets BCL2 mRNA and BCL2L1 mRNA.

  • GC81827 structure
    GC81827Buforin IIb TFA
    Purity: >98.00%

    Buforin IIb TFA (BF2-B TFA) is an anticancer peptide, as well as an Antibacterial and Antifungal agent.

  • GC81835 structure
    GC81835G4232
    Purity: >98.00%

    G4232 is an immune-silent BCL2 antisense oligonucleotide that binds to BCL2 mRNA to induce target degradation and inhibit Bcl-2 protein translation.

  • GC81842 structure
    GC81842Lck Inhibitor III free base
    CAS: 918870-44-7
    Purity: >98.00%

    Lck Inhibitor III free base is a Lck inhibitor with an IC 50 of 867 nM.

  • GC81846 structure
    GC81846Nivitol
    CAS: 869743-37-3
    Purity: >98.00%

    Nivitol (UP302) is a natural phenolic compound discovered from Dianella ensifolia and also acts as a Tyrosinase inhibitor.

  • GC81850 structure
    GC81850p53 Bipartite NLS TFA
    Purity: >98.00%

    p53 Bipartite NLS TFA is a bipartite nuclear localization signal derived from p53.